Association between use of ß2-adrenergic receptor agonists and incidence of Parkinson's disease: Retrospective cohort analysis.
<h4>Introduction</h4>Previous observational studies assessing β2-agonist/-antagonist use on PD risk have yielded conflicting results. We evaluated the relationship between β2-agonist use and the incidence of Parkinson's disease in patients with chronic lung disease.<h4>Methods...
Main Authors: | Hasan Nadeem, Bo Zhou, Dana Goldman, John Romley |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0276368 |
Similar Items
-
Association between use of ß2-adrenergic receptor agonists and incidence of Parkinson’s disease: Retrospective cohort analysis
by: Hasan Nadeem, et al.
Published: (2022-01-01) -
Association between exenatide use and incidence of Alzheimer's disease
by: Bo Zhou, et al.
Published: (2021-01-01) -
Risk of childhood cerebral palsy following prenatal exposure to ß2-adrenergic receptor agonist: A nationwide cohort study.
by: Lin Li, et al.
Published: (2018-01-01) -
Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients.
by: Bettina Hohberger, et al.
Published: (2021-01-01) -
Agonist-directed desensitization of the β2-adrenergic receptor.
by: Vasiliy Goral, et al.
Published: (2011-04-01)